Jörgensen et al., 1972 - Google Patents
Serogenetic investigations on malignant melanomas with reference to the incidence of AB0 system, Rh system, Gm, Inv, Hp and Gc systemsJörgensen et al., 1972
- Document ID
- 8977486577877635704
- Author
- Jörgensen G
- Lal V
- Publication year
- Publication venue
- Humangenetik
External Links
Snippet
An investigation on 164 probands with malignant melanomas has been carried out with reference to blood groups, AB0, Rh types, serum groups including Gm 1, Gm 2, Inv 1, Hp and Gc factors. The observations were compared with a large number of normal individuals …
- 201000001441 melanoma 0 title abstract description 29
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seibert | The isolation of three different proteins and two polysaccharides from tuberculin by alcohol fractionation. Their chemical and biological properties | |
| DE3587022D1 (en) | HUMAN TRANSFORMATION GROWTH FACTOR AND PRECURSOR OR FRAGMENT THEREOF, CELLS, DNA, VECTORS AND METHODS FOR THE PRODUCTION THEREOF, COMPOSITIONS AND PRODUCTS THAT CONTAIN THESE, AND ANTI-OXIDERS AND DIAGNOSTICS DERIVED FROM THEM. | |
| Edelson et al. | The immunologic function of skin | |
| Laurenzi et al. | The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide | |
| Click et al. | Enhancement of antibody synthesis in vitro by mercaptoethanol | |
| Jörgensen et al. | Serogenetic investigations on malignant melanomas with reference to the incidence of AB0 system, Rh system, Gm, Inv, Hp and Gc systems | |
| DE3110610A1 (en) | CHEMOKINESINE AND CHEMOTAXINE OF LEUKOCYTES AND INFLAMMATORY TISSUE: NATURAL MEDIATORS FOR SELECTIVE REVERSIBLE MOTILITY INFLUENCE (CHEMOKINESIS) AND CHEMICAL ATTRACTION (CHEMOTAXIS) IN THE COLLECTION OF LEUKO | |
| Mangalik et al. | Cyclic neutropenia: the relationship between urine granulocyte colony stimulating activity and neutrophil count | |
| Williams et al. | The further fractionation of yeast nutrilites and their relationship to vitamin B and Wildiers'“bios” | |
| Metcalf et al. | Periodic Acid–Schiff Positive Giant Cells in the Mouse Thymus Cortex | |
| DE2518474A1 (en) | MITOGENIC PRODUCT, THE METHOD OF MANUFACTURING IT, AND MEDICINAL PRODUCTS AND BIOLOGICAL REAGENTS CONTAINING THESE MEANS | |
| Dwivedi et al. | Isolation and characterization of chromatin from Neurospora crassa | |
| DE2352662A1 (en) | METHOD FOR PRODUCING A TRANSFER FACTOR | |
| Kemp et al. | Suppression and enhancement of in vitro lymphocyte reactivity by factors in rat submandibular gland extracts. | |
| Silverman jr et al. | Tissue-Culture Studies of Human Oral Carcinoma 1. Proliferative Capacities of Non-malignant and Malignant Oral Explants | |
| DE3110611A1 (en) | "MITOGENES OF LEUCOCYTES AND INFLAMMATION TISSUE: NATURAL LEUKOPOETINS FOR SELECTIVE EXCITATION OF THE DIVISION AND DIFFERENTIATION OF LEUKOCYTES" | |
| EP0889053B1 (en) | BK-RiV preparations for teatment of proliferative cellular disorders | |
| Morag | Influence of diet on the behaviour pattern of sheep | |
| DE3783511T2 (en) | METHOD FOR BREEDING ANIMAL CELLS AND SUITABLE MEDIA. | |
| Torgerson et al. | The same fractions of Haemonchus contortus soluble antigen induce lymphocyte responses in naive lambs and immune sheep | |
| SU1730594A1 (en) | Method of interleukin-1 determination in human monocytes | |
| WO2003080122A1 (en) | Method and agent for producing therapeutically active blood compositions | |
| DE69632066T2 (en) | METHOD OF CLEANING THE UREASE FROM HELICOBACTER PYLORI | |
| Cavaillon et al. | Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A | |
| CN103864915A (en) | Method for purifying recombinant human interferon alpha2b and kit |